FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096579084> ?p ?o ?g. }

• W2096579084 endingPage "2458" @default.
• W2096579084 startingPage "2448" @default.
• W2096579084 abstract "To investigate nuclear localized and tyrosine phosphorylated Stat5 (Nuc-pYStat5) as a marker of prognosis in node-negative breast cancer and as a predictor of response to antiestrogen therapy.Levels of Nuc-pYStat5 were analyzed in five archival cohorts of breast cancer by traditional diaminobenzidine-chromogen immunostaining and pathologist scoring of whole tissue sections or by immunofluorescence and automated quantitative analysis (AQUA) of tissue microarrays.Nuc-pYStat5 was an independent prognostic marker as measured by cancer-specific survival (CSS) in patients with node-negative breast cancer who did not receive systemic adjuvant therapy, when adjusted for common pathology parameters in multivariate analyses both by standard chromogen detection with pathologist scoring of whole tissue sections (cohort I; n = 233) and quantitative immunofluorescence of a tissue microarray (cohort II; n = 291). Two distinct monoclonal antibodies gave concordant results. A progression array (cohort III; n = 180) revealed frequent loss of Nuc-pYStat5 in invasive carcinoma compared to normal breast epithelia or ductal carcinoma in situ, and general loss of Nuc-pYStat5 in lymph node metastases. In cohort IV (n = 221), loss of Nuc-pYStat5 was associated with increased risk of antiestrogen therapy failure as measured by univariate CSS and time to recurrence (TTR). More sensitive AQUA quantification of Nuc-pYStat5 in antiestrogen-treated patients (cohort V; n = 97) identified by multivariate analysis patients with low Nuc-pYStat5 at elevated risk for therapy failure (CSS hazard ratio [HR], 21.55; 95% CI, 5.61 to 82.77; P < .001; TTR HR, 7.30; 95% CI, 2.34 to 22.78; P = .001). CONCLUSION Nuc-pYStat5 is an independent prognostic marker in node-negative breast cancer. If confirmed in prospective studies, Nuc-pYStat5 may become a useful predictive marker of response to adjuvant hormone therapy." @default.
• W2096579084 created "2016-06-24" @default.
• W2096579084 creator A5000337505 @default.
• W2096579084 creator A5002313413 @default.
• W2096579084 creator A5005195742 @default.
• W2096579084 creator A5007249612 @default.
• W2096579084 creator A5011656765 @default.
• W2096579084 creator A5014595154 @default.
• W2096579084 creator A5018913181 @default.
• W2096579084 creator A5020006664 @default.
• W2096579084 creator A5027326018 @default.
• W2096579084 creator A5034535391 @default.
• W2096579084 creator A5061721402 @default.
• W2096579084 creator A5065798455 @default.
• W2096579084 creator A5069051634 @default.
• W2096579084 creator A5072652868 @default.
• W2096579084 creator A5079816358 @default.
• W2096579084 creator A5080198756 @default.
• W2096579084 creator A5080487628 @default.
• W2096579084 creator A5081489838 @default.
• W2096579084 creator A5082905275 @default.
• W2096579084 date "2011-06-20" @default.
• W2096579084 modified "2023-10-06" @default.
• W2096579084 title "Loss of Nuclear Localized and Tyrosine Phosphorylated Stat5 in Breast Cancer Predicts Poor Clinical Outcome and Increased Risk of Antiestrogen Therapy Failure" @default.
• W2096579084 cites W1486018587 @default.
• W2096579084 cites W1898692666 @default.
• W2096579084 cites W1969726357 @default.
• W2096579084 cites W1977315250 @default.
• W2096579084 cites W1982703106 @default.
• W2096579084 cites W1983724690 @default.
• W2096579084 cites W1986137495 @default.
• W2096579084 cites W1989790390 @default.
• W2096579084 cites W1992316503 @default.
• W2096579084 cites W1998051987 @default.
• W2096579084 cites W2011030679 @default.
• W2096579084 cites W2016569614 @default.
• W2096579084 cites W2032563527 @default.
• W2096579084 cites W2034831048 @default.
• W2096579084 cites W2038451517 @default.
• W2096579084 cites W2048477123 @default.
• W2096579084 cites W2064800534 @default.
• W2096579084 cites W2068822211 @default.
• W2096579084 cites W2077689919 @default.
• W2096579084 cites W2083064254 @default.
• W2096579084 cites W2106642283 @default.
• W2096579084 cites W2117305280 @default.
• W2096579084 cites W2122615310 @default.
• W2096579084 cites W2123179063 @default.
• W2096579084 cites W2133196685 @default.
• W2096579084 cites W2133650808 @default.
• W2096579084 cites W2138314001 @default.
• W2096579084 cites W2139206204 @default.
• W2096579084 cites W2140423876 @default.
• W2096579084 cites W2143396070 @default.
• W2096579084 cites W2143584784 @default.
• W2096579084 cites W2147028876 @default.
• W2096579084 cites W2148320836 @default.
• W2096579084 cites W2155454155 @default.
• W2096579084 cites W2158961508 @default.
• W2096579084 cites W2167907059 @default.
• W2096579084 cites W2196919854 @default.
• W2096579084 cites W2312984480 @default.
• W2096579084 cites W2321112275 @default.
• W2096579084 cites W2407901362 @default.
• W2096579084 doi "https://doi.org/10.1200/jco.2010.30.3552" @default.
• W2096579084 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3675698" @default.
• W2096579084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21576635" @default.
• W2096579084 hasPublicationYear "2011" @default.
• W2096579084 type Work @default.
• W2096579084 sameAs 2096579084 @default.
• W2096579084 citedByCount "95" @default.
• W2096579084 countsByYear W20965790842012 @default.
• W2096579084 countsByYear W20965790842013 @default.
• W2096579084 countsByYear W20965790842014 @default.
• W2096579084 countsByYear W20965790842015 @default.
• W2096579084 countsByYear W20965790842016 @default.
• W2096579084 countsByYear W20965790842017 @default.
• W2096579084 countsByYear W20965790842018 @default.
• W2096579084 countsByYear W20965790842019 @default.
• W2096579084 countsByYear W20965790842020 @default.
• W2096579084 countsByYear W20965790842021 @default.
• W2096579084 countsByYear W20965790842022 @default.
• W2096579084 countsByYear W20965790842023 @default.
• W2096579084 crossrefType "journal-article" @default.
• W2096579084 hasAuthorship W2096579084A5000337505 @default.
• W2096579084 hasAuthorship W2096579084A5002313413 @default.
• W2096579084 hasAuthorship W2096579084A5005195742 @default.
• W2096579084 hasAuthorship W2096579084A5007249612 @default.
• W2096579084 hasAuthorship W2096579084A5011656765 @default.
• W2096579084 hasAuthorship W2096579084A5014595154 @default.
• W2096579084 hasAuthorship W2096579084A5018913181 @default.
• W2096579084 hasAuthorship W2096579084A5020006664 @default.
• W2096579084 hasAuthorship W2096579084A5027326018 @default.
• W2096579084 hasAuthorship W2096579084A5034535391 @default.
• W2096579084 hasAuthorship W2096579084A5061721402 @default.
• W2096579084 hasAuthorship W2096579084A5065798455 @default.
• W2096579084 hasAuthorship W2096579084A5069051634 @default.
• W2096579084 hasAuthorship W2096579084A5072652868 @default.

• next